FIRST KEYSTONE ANNOUNCES SECOND QUARTER 2026 EARNINGS (UNAUDITED)

FIRST KEYSTONE CORP (FKYS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FIRST KEYSTONE ANNOUNCES SECOND QUARTER 2026 EARNINGS (UNAUDITED) ​ Berwick, Pennsylvania – July 30, 2026 - First Keystone Corporation (OTCID: FKYS), parent company of First Keystone Community Bank, reported an increase in total interest income of $2,124,000 or 5.7%,

Original reporting
Published Aug 3, 2026, 4:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 3, 2026, 4:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$FKYS
Neutral
low confidence
Mentioned
$FKYS
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$FKYSNeutralLow
01

Why it matters

The filing itself is the primary disclosure that earnings were announced and that the press release is attached as Exhibit 99.1, but the scraped content does not include the earnings figures or management commentary needed to forecast price impact.

02

Market read

Confirms a new earnings event for FKYS, but without the Exhibit 99.1 financial details, it offers limited immediate trading insight.

03

What to watch

For community banks, the market often reacts more to credit quality and deposit trends than headline earnings; those details are not present in the scraped body, so the provided text may understate the true catalyst.

Relevance 7/10Novelty 3/10Timing: Filed Aug 3, 2026 after-hours/late session, referencing Q2 results for period ended June 30, 2026.

Background

The article is an SEC Form 8-K (Item 2.02) from First Keystone Corporation, parent of First Keystone Community Bank, stating it announced unaudited earnings for the quarter ended June 30, 2026.

Company-level read

Ticker impact

$FKYSNeutralLow confidence
Context

First Keystone Corporation filed an 8-K stating it announced unaudited Q2 2026 earnings for the period ended June 30, 2026, with the press release as Exhibit 99.1.

Expected impact

Near-term volatility possible around the Exhibit 99.1 earnings details, but direction cannot be inferred from the provided text.

Evidence & confidence

The filing confirms earnings were announced and incorporated via Exhibit 99.1, yet the article body provides no numbers, guidance, or qualitative drivers.

Market effects

Limited sector read-through because the text contains no bank-specific metrics (credit quality, NIM, deposits, or guidance).

Potentially local/regional relevance for Pennsylvania community banking, but no regional data is disclosed here.

Negligible, as this is a small OTC-listed bank filing with no macro or cross-asset linkage in the provided text.

Counterpoint

Traders may treat this as a routine filing template and wait for the actual Exhibit 99.1 earnings release to extract the real drivers before reacting.

Key entities

  • First Keystone Corporation

    OTC-listed parent company of First Keystone Community Bank; filed 8-K Item 2.02 referencing unaudited Q2 2026 earnings.

  • First Keystone Community Bank

    Bank subsidiary referenced as the operating entity behind the parent’s earnings disclosure.

Related articles

$FKYSMed

FIRST KEYSTONE ANNOUNCES THIRD QUARTER 2026 EARNINGS (UNAUDITED)

FIRST KEYSTONE CORP (FKYS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FIRST KEYSTONE ANNOUNCES THIRD QUARTER 2026 EARNINGS (UNAUDITED) ​ Berwick, Pennsylvania – October 30, 2026 - First Keystone Corporation (OTCID: FKYS), parent company of First Keystone Community Bank, reported an increase in total interest income of $3,195,000 or 5.6

$PTHSMed

Pelthos (PTHS) Q3 2026 Earnings Call Transcript

Pelthos (PTHS) reported Q3 2026 net revenue of $15.2M, up 114% YoY, with Zelsuvmi treating 31,000 patients. Formulary coverage expanded to 70% of commercial lives. The company announced a deal with Castle Creek Biosciences, aiming to leverage synergies in dermatology and cell/gene therapy markets. Xepi and Xeglyze launches are planned for 2027.

$BMNRMedAI 8/10

Bitmine’s ($BMNR) $6.3 Billion Loss Highlights Overall Risks for Strategy ($MSTR) and Other Treasury Firms as MSCI Tightens Rules

Bitmine Immersion Technologies (BMNR) reported a $6.3B net loss for fiscal 2026, driven by $6.23B in unrealized losses on digital-asset holdings, primarily ether. The company held 5.9M ether tokens and 211 bitcoin at year-end. Operating revenue was $125M, with staking contributing 97%. MSCI's updated index rules may impact BMNR and other crypto-focused treasury firms, including Strategy (MSTR).

HighAI 8/10

Merck KGaA Earnings Call Signals Stronger Growth Ahead

Merck KGaA (MKKGY) reported Q3 earnings with accelerated growth, raised full-year guidance, and announced strategic investments. Key highlights include 5.1% organic sales growth, EUR 1.66B operating cash flow, and plans to acquire Silence Therapeutics. Management emphasized growth in biomanufacturing, semiconductors, and rare diseases, while noting Mavenclad's declining sales and softer demand in consumer electronics.

$EZPWMed

EZCORP shares fall despite record Q4 as costs overshadow beat

EZCORP (EZPW) reported Q4 revenue of $447M, beating estimates, with full-year revenue up 30% to $1.7B and adjusted EBITDA up 47% to $277M. Despite strong results, shares fell 4.13% due to concerns about labor costs and integration timing in Latin America. Insiders filed SEC disclosures, and short-sale activity increased ahead of the earnings release.